posted on 2012-03-26, 15:18authored byMartin D. Haustein
Severe neonatal jaundice causes bilirubin encephalopathy with complications
such as ataxia, delayed neurodevelopment and deafness. The hair cells in the
cochlea are spared suggesting central damage but the underlying mechanisms
for this hearing loss are unknown. Utilising the Gunn rat model of
hyperbilirubinemia I investigated the detrimental effect of high levels of bilirubin
on the hearing system, using electrophysiological and imaging techniques
combined with in vivo and in vitro studies of the auditory brainstem. My studies
have focussed on synaptic transmission between the well characterised giant
synapse called the calyx of Held and its target, the principal neuron of the
Medial Nucleus of the Trapezoid Body (MNTB), as a model synapse.
In vivo auditory brainstem responses (ABR) revealed a significant loss of
sound-evoked brainstem activity and increased thresholds after homozygous
Gunn rats were exposed to elevated bilirubin levels. Extracellular field potential
recordings from the MNTB in vitro using multi-electrode arrays showed
impaired synaptic transmission. Whole-cell patch-clamp recordings from MNTB
neurons confirmed that their electrophysiological properties remain essentially
normal. Significantly, synaptic stimulation failed to elicit EPSCs from the giant
synapse, with only smaller synaptic inputs being activated in homozygous Gunn
rats exposed to elevated bilirubin levels. Multiphoton imaging of dextranrhodamine
labelled calyces in living brain slices revealed degeneration of the
presynaptic terminals in Gunn rats exposed to high bilirubin. Electron
microscopic images confirmed the loss of the presynaptic terminals observed in
living tissue with no sign of degeneration in postsynaptic neurons. The use of
neuronal nitric oxide synthase antagonist 7-nitroindazole protected the ABRs
and the synaptic transmission in the MNTB. This implicates nitric oxide as
playing a key role in bilirubin-induced neurodegeneration of the presynaptic
terminals.
This research demonstrates for the first time that deafness associated with
jaundice is fundamentally a neurodegenerative disease and suggests some
novel therapeutic strategies.